Novanta Inc NOVT
We take great care to ensure that the data presented and summarized in this overview for NOVANTA INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding NOVT
View all-
Black Rock Inc. New York, NY4.41MShares$695 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.38MShares$691 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC1.41MShares$223 Million3.58% of portfolio
-
State Street Corp Boston, MA1.31MShares$206 Million0.01% of portfolio
-
Geneva Capital Management LLC979KShares$154 Million2.68% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD972KShares$153 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL961KShares$152 Million0.42% of portfolio
-
Geode Capital Management, LLC Boston, MA905KShares$143 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT832KShares$131 Million0.73% of portfolio
-
Allspring Global Investments Holdings, LLC795KShares$126 Million0.22% of portfolio
Latest Institutional Activity in NOVT
Top Purchases
Top Sells
About NOVT
Novanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The company's Photonics segment offers photonics-based solutions, including laser scanning and beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. It's Vision segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless technologies, video recorders, and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions. In addition, its Precision Motion segment offers optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-of-arm technology solutions, air bearings, and air bearing spindles. The company sells its products through its direct sales force, resellers, distributors, and system integrators under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, Celera Motion, MicroE, Zettlex, Applimotion, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was founded in 1968 and is headquartered in Bedford, Massachusetts.
Insider Transactions at NOVT
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2025
|
Matthijs Glastra Chief Executive Officer |
BUY
Bona fide gift
|
Direct |
15,693
+15.53%
|
-
|
|
Dec 02
2025
|
Matthijs Glastra Chief Executive Officer |
SELL
Bona fide gift
|
Indirect |
15,693
-100.0%
|
-
|
|
Sep 10
2025
|
Matthijs Glastra Chief Executive Officer |
BUY
Bona fide gift
|
Direct |
41,487
+37.32%
|
-
|
|
Sep 10
2025
|
Matthijs Glastra Chief Executive Officer |
SELL
Bona fide gift
|
Indirect |
41,487
-100.0%
|
-
|
|
Jul 11
2025
|
Mary Kay Ladone Director |
BUY
Exercise of conversion of derivative security
|
Direct |
572
+50.0%
|
-
|
|
May 08
2025
|
Robert Matthew Johnson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
818
+50.0%
|
-
|
|
Apr 21
2025
|
Charles Guy Ravetto Jr Co-Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,418
-13.16%
|
$375,980
$110.54 P/Share
|
|
Apr 21
2025
|
Charles Guy Ravetto Jr Co-Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,421
+26.21%
|
-
|
|
Feb 24
2025
|
Robert Buckley Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,623
-2.8%
|
$361,974
$138.3 P/Share
|
|
Feb 24
2025
|
Robert Buckley Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,425
+5.48%
|
-
|
|
Feb 24
2025
|
John Joseph Burke Ii Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
277
-1.76%
|
$38,226
$138.3 P/Share
|
|
Feb 24
2025
|
John Joseph Burke Ii Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
872
+5.24%
|
-
|
|
Feb 24
2025
|
Charles Guy Ravetto Jr Co-Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
242
-3.27%
|
$33,396
$138.3 P/Share
|
|
Feb 24
2025
|
Charles Guy Ravetto Jr Co-Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
824
+10.02%
|
-
|
|
Feb 24
2025
|
Matthijs Glastra Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,247
-15.69%
|
$724,086
$138.3 P/Share
|
|
Feb 24
2025
|
Matthijs Glastra Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,851
+24.5%
|
-
|
|
Feb 21
2025
|
John Joseph Burke Ii Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
180
-2.41%
|
$25,200
$140.51 P/Share
|
|
Feb 21
2025
|
John Joseph Burke Ii Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
518
+6.47%
|
-
|
|
Feb 21
2025
|
Charles Guy Ravetto Jr Co-Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
349
-5.04%
|
$48,860
$140.51 P/Share
|
|
Feb 21
2025
|
Charles Guy Ravetto Jr Co-Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,058
+13.25%
|
-
|
Last 12 Months Summary
| Exercise of conversion of derivative security | 37.7K shares |
|---|---|
| Grant, award, or other acquisition | 27.5K shares |
| Bona fide gift | 93.4K shares |
| Payment of exercise price or tax liability | 25.2K shares |
|---|---|
| Bona fide gift | 93.4K shares |